SuperworthBruker EPS BRKR
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$0.70
- Latest quarter, Q2 FY26
- −$0.41
- −920% on a year earlier
- Fiscal year 2025
- −$0.15
- −120% on the year before
Bruker's earnings per share was −$0.70 over the twelve months to Jun 30, 2026, down 235% on a year earlier.
In its latest quarter, Q2 FY26, it was −$0.41, down 920% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$0.15 | −120% |
| FY2024 | $0.76 | −74% |
| FY2023 | $2.91 | +46% |
| FY2022 | $1.99 | +9% |
| FY2021 | $1.82 | +77% |
| FY2020 | $1.03 | −18% |
| FY2019 | $1.26 | +10% |
| FY2018 | $1.15 | +135% |
| FY2017 | $0.49 | −48% |
| FY2016 | $0.95 | +58% |
| FY2015 | $0.60 | +82% |
| FY2014 | $0.33 | −31% |
| FY2013 | $0.48 | +2% |
| FY2012 | $0.47 | −15% |
| FY2011 | $0.55 | −7% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.41 | −920% | −$0.70 | |
| Q1 FY26 | $0.02 | −82% | −$0.24 | |
| Q4 FY25 | $0.10 | +11% | −$0.15 | |
| Q3 FY25 | −$0.41 | −252% | −$0.16 | |
| Q2 FY25 | $0.05 | +0% | $0.52 | |
| Q1 FY25 | $0.11 | −69% | $0.52 | |
| Q4 FY24 | $0.09 | −94% | $0.76 | |
| Q3 FY24 | $0.27 | −55% | $2.07 | |
| Q2 FY24 | $0.05 | −87% | $2.40 | |
| Q1 FY24 | $0.35 | −33% | $2.74 | |
| Q4 FY23 | $1.40 | +112% | $2.91 | |
| Q3 FY23 | $0.60 | +2% | $2.17 |
Against its peers
Companies in Medical - Diagnostics & Research nearest Bruker's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| BRKRBruker | −$0.70 | −235% a year |
| CAICaris Life Sciences | $0.37 | |
| BIOBio-Rad Laboratories | $8.25 | −30% a year |
| LNTHLantheus | $4.13 | +10% a year |
| BLLNBillionToOne | $0.65 | |
| RVTYRevvity | $2.10 | −11% a year |
| MEDPMedpace | $17.05 | +27% a year |
| VCYTVeracyte | $1.40 | +324% a year |
| CDNACareDx | $2.07 | +116% a year |
| LHLabcorp | $12.09 | +33% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| Peer median | $3.12 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Bruker
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.